Clinical Trial Update: Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients [NA]

View source ↗

Summary

A completed clinical trial (NCT02084407) investigating induction of pluripotent stem cells from human fibroblasts of patients with myotonic dystrophy type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Snippet

Sponsor: Institut de Myologie, France | Conditions: DM1 | NA | Status: COMPLETED